Connect with us
The French laboratory Pierre Fabre announced an investment of $5.3 million (€4.5 million) to produce the active ingredients for binimetinib and encorafenib at its Gaillac site....
Innate Pharma is specialized in the discovery, development and commercialization of first-in-class therapeutic antibodies exploiting the immune system to treat cancers in strong medical need. The...